Genesys International: CARE Monitoring Report Highlights QIP Deviations and Utilization Timeline Delays
Genesys International Corporation Ltd · Others (Uncategorized) · 14 Nov 2026, 2:33 am
Genesys International: CARE Monitoring Report Highlights QIP Deviations and Utilization Timeline Delays CARE Ratings' monitoring report for the quarter ended 30th Sep'26 highlighted deviations in Genesys International's ₹110.00 crore QIP proceeds. An amount of ₹6.60 crore was temporarily diverted to non-specified purposes via current account transfers before being returned on 3rd Sep'26. Additionally, utilization of ₹75.29 crore faces delays, extending the timeline from 31st Mar'26 to 31st Mar'27. Total QIP deployment reached ₹46.62 crore, with ₹63.38 crore unutilized. Meanwhile, proceeds from its ₹125.37 crore Rights Issue saw ₹41.72 crore utilized with zero deviations reported.
Original exchange filing (PDF)
More announcements from Genesys International Corporation Ltd
- Genesys International Corporation Limited has informed the Exchange regarding Grant of Stock options 3,65,000 under Genesys Employee Option Scheme, 2022 ( Scheme) · 14 Nov 2026
- Outcome of Board Meeting held on November 13, 2026 regarding approval of Unaudited Standalone & Consolidated Financial Result for the quarter and half year ended September 30, 2026 · 14 Nov 2026
- Press release issued by Genesys International Corporation Limited regarding Unaudited Standalone & Consolidated Financial Results for the quarter ended September 30, 2026 · 14 Nov 2026
- Genesys International Corporation Limited has informed the exchange regarding Unaudited Standalone and Consolidated Financial Result for the quarter and half year ended September 30, 2026 · 14 Nov 2026
- Genesys International Corporation Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Genesys International Corporation Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 13 Nov 2026
- Genesys International Corporation Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 13 Nov 2026
- Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-Audited .... · 13 Nov 2026
